Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells

Stem Cells

Volumn 19, Issue 4, 2001, Pages 313-320

  Rossmanith T ^a   Schroder B ^b   Bug, G ^a,d   Muller P ^c   Klenner, T ^c   Knaus, R ^b   Hoelzer, D ^a   Ottmann, O G ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b MainGen Biotechnologie GmbH   (Germany)

^c ASTA MEDICA AG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Ex vivo expansion; Interleukin 3; NOD SCID model; Stem cells; Umbilical cord blood

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CELL TRANSPLANTATION; COLONY FORMING CELL; COMBINED IMMUNODEFICIENCY; DIAGNOSTIC ERROR; HUMAN; HUMAN CELL; LETHALITY; LONG TERM CARE; MEMBRANE RECONSTITUTION; MOUSE; NONHUMAN; RADIATION RESPONSE; STEM CELL; UMBILICAL CORD BLOOD;

ANIMALIA;

EID: 17144458731     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-4-313     Document Type: Article

References (40)

1. Cord blood banking and transplant in Europe
2. Outcomes among 562 recipients of placental-blood transplants from unrelated donors
3. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
4. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor cell content is a better predictor than nucleated cell quantity
5. Identificafion of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
6. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells
7. Expansion in vitro of transplantable human cord blood stem cells demontrated using a quantitafive assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
8. Sustained proliferation, multi-lineage differentiation and maintenance of primitive human hematopoietic cells in NOD/SCID mice transplanted with human cord blood
9. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice
10. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
11. Transplantation of cancer patients receiving high dose chemotherapy with ex vivo expanded cord blood cells
12. Cord blood stem cell transplantation
13. Differential maintenance of primitive human SCID- repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells
14. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens
15. + blood progenitor cells
16. Differentiation and proliferation of hematopoietic stem cells
17. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors
18. - cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1 alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay
19. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells
20. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: Transduction of the negative signals by beta-c and beta-IL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor
21. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro
22. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability
23. High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo
24. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand
25. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3
26. -) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoetin
27. - cells and maintains progenitor cells in vitro
28. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood
29. Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1 alpha
30. + cord blood cells
31. + cells expands progenitor cells numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency
32. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
33. Engraftment of cultured human hematopoietic cells in sheep
34. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture
35. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables
36. Cytokine manipulation of primitive human hematopoietic cell self-renewal
37. 0
38. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal derived factor-1
39. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
40. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1